REV1 and adenocarcinoma: Polymorphisms in REV1 and POLI, leading to single amino acid substitutions in Rev1 and Pol ι, were associated with increased risk of squamous cell carcinoma and adenocarcinoma, respectively (152), while POLH polymorphisms are associated with increased risk of malignant melanoma (153).